Pharmafile Logo

Stronger Together: Medscape Education Celebrates Accomplishments in Rare Disease and Anticipates the World Health Assembly Adoption of the Resolution on Rare Diseases

Medscape Education is proud to be showcasing the power of working together in rare disease education and advocacy by co-hosting a side event at the 78th World Health Assembly in Geneva, Switzerland on May 21, 2025. This event, Milestones & Momentum in Rare Disease, celebrates the accomplishments of rare disease advocacy and anticipates the adoption of a WHA Resolution on Rare Diseases with the aim of making rare diseases a global health priority for equity and inclusion, touching the lives of the more than 300 million people worldwide who live with a rare disease.

- PMLiVE

The resolution, proposed by the Arab Republic of Egypt and Spain, and co-sponsored by 27 other Member States, calls for nations to commit to a global action plan on rare diseases (GAPRD) which includes “further increasing awareness and education initiatives about rare diseases among healthcare providers, policy-makers and the public in order to promote understanding of and support for affected individuals.” 

Co-hosts of the event include Rare Diseases International, the Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease, Sant Joan de Déu Barcelona Hospital, the Harriet Joyce Foundation, the World Federation of Hemophilia, and the Wilhelm Foundation.

In 2021, Medscape Education launched what is now the largest collection of rare disease education for clinicians with their Pathways in Rare Disease learning center. The dedicated learning destination provides free education for the entire care team, and has now featured more than 360 educational activities across more than 100 different rare conditions. Since its launch, the learning center has reached more than 2.3 million healthcare professional learners with accredited education delivered by leading faculty from  around the world. 

“It has been so rewarding to see the impact that Medscape Rare Disease Education has had on real world diagnosis and management. With the adoption of the resolution at the 78th World Health Assembly, Medscape will be a key player, ready to implement the GAPRD in collaboration with diverse stakeholders, to reduce diagnostic delays and enable earlier access to treatment,” said S. Christy Rohani-Montez, PhD, Rare Disease Education Lead at Medscape Education Global. Dr Rohani-Montez will take part in a panel at the event.

For more information on rare disease education at Medscape Education, please contact S. Christy Rohani-Montez at srohani@medscape.net.

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Contagious Conversations: Exploring Infectious Disease in the Digital Age

As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...

Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens

From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...

Impacting Lives with Rare Disease Education

Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...

Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D

An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...

A Rare Disease Update from Medscape Education

A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency

New Outcomes Are a Breath of Fresh Air at ERS

ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...

Medscape Education Launches 20th Older Driver Safety Educational Program

Education Supported by the National Highway Traffic Safety Administration

Protecting the Heart Through Education at ESC 2023

Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...

Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners

The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...

Continuing Medical Education Outcomes are Much More Than Statistical Significance

At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...